Compare Intuitive Surgical, Inc. (ISRG) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Jabil Inc — how do they compare? Intuitive Surgical, Inc. trades at $418.69 (market cap $146.76B), while Jabil Inc trades at $303.26 (market cap $31.35B). The key difference: Intuitive Surgical, Inc. is far larger — about 4.7× Jabil Inc's market cap, and Jabil Inc pays a 0.11% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Jabil Inc for 23 Days on average.
| ISRG | JBL | |
|---|---|---|
Market Cap | $146.76B | $31.35B |
Volume | 2,529,814 | 1,337,978 |
Sector | Health | Technology |
52-Week High | $592.85 | $385.50 |
52-Week Low | $332.02 | $192.49 |
Typical Hold Time | 84 Days | 23 Days |
Enterprise Value | $141.54B | $33.63B |
Dividend Yield | — | 0.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $414.52, up 2.41% with strong bullish technical signals and consistent earnings beats. The company demonstrates robust fundamentals with 2025 revenue reaching $10.06 billion and net income of $2.86 billion, maintaining impressive profit margins above 28%. Recent expansion into ambulatory surgery centers and international markets like India and Japan provides growth catalysts, though China headwinds present challenges. Technical indicators show bullish momentum with support at $411 and resistance at $417.
ISRG presents a compelling growth story with dominant market positioning in robotic surgery and strong recurring revenue streams. The stock offers 16% upside to the consensus price target of $480.78, supported by 70% analyst buy ratings. Key risks include competitive pressures in robotic surgery and international market volatility. The company's consistent earnings outperformance and expanding global footprint suggest continued growth potential despite near-term headwinds.
JBL trades at $299.47, down 3.14% amid bearish technical signals despite strong Q4 2026 earnings that beat estimates with EPS of $4.40 versus $4.07 expected. The stock shows neutral oscillators but bearish moving averages, with support at $296 and resistance at $303. Revenue grew to $29.80B in 2025 with net income of $657M, while 2026 projections indicate $36.0B revenue and $1.0B net income, supported by AI infrastructure demand.
Outlook remains positive with 60.87% analyst buy ratings and a $434.75 consensus price target implying 45% upside. Key risks include high debt levels and market volatility, but strong earnings momentum and AI-driven growth in fiscal 2027 provide investment opportunity. Monitor execution against guidance and macroeconomic conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
